MoneyWorks4Me

Gujarat Themis Biosyn implements new business model

26 Sep 2019 Evaluate

Gujarat Themis Biosyn has implemented its new business model of manufacturing and supply of pharmaceutical products to various parties.

Gujarat Themis Biosyn is a biotech and synthetic product manufacturing company. The company’s principal activity is to manufacture and distributes pharmaceuticals bulk drugs called rifampicin produced by fermentation process. The company's products include preparations of active pharmaceutical ingredient rifampicin and lovastatin. The company exports its products to Europe and the United States. 

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..